The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
NCT ID: NCT01599845
Last Updated: 2012-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2012-05-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Induced Sputum and Lung Biopsies by SEM: a Tool to Identify Source of Exposure of Workers to Hazardous Dust
NCT00511251
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT03839537
Airway Inflammation Among Workers in the Silicon Carbide Processing Industry
NCT01337180
Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:
NCT02872727
Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function
NCT03098784
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Does occupational exposure to nanoparticles influence permeation of such particles to respiratory airways? Is there a correlation between the levels of nanoparticles in sample biological fluids of the patients and their pulmonary functions.
Is there a correlation between the levels of nanoparticles in sample biological fluids of the patients and respiratory tract infections.
The study protocol includes the following steps:
Initial interview of the patient Measurement of nanoparticles in samples of exhaled breath condensate using NanoSight LM 20 Measurement of nanoparticles in induced sputum. And finally examination of the relationship between the measured parameters and the indices of pulmonary infection, and pulmonary function as measured by the pulmonary department of the TASMC.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nanoparticle exposed
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Study population is composed of people who are exposed to environmental particles form industrial sources.
* Informed consent is requested from each subject.
Exclusion Criteria
* Individuals who are not working in industrial jobs, such as office workers and secretaries.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yehuda Schwarz, M.D.
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv Sourasky Medical Center (TASMC, Ichilov)
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-11-YS-0107-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.